# A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

> **NCT07482319** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Geekgene Technology Co., LTD** · enrollment: 15 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** GK01 injection

## Key facts

- **NCT ID:** NCT07482319
- **Lead sponsor:** Beijing Geekgene Technology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2028-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482319, "A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07482319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*